Ranbaxy Loses Bid To Make Generic Flomax

Law360, New York (February 23, 2007, 12:00 AM EST) -- A U.S. federal judge has squashed an attempt by Indian generic drug maker Ranbaxy Laboratories Ltd. to make its own version of Flomax, the enlarged-prostate treatment developed by Japanese pharmaceutical firm Astellas Pharma Inc.

The decision, issued Feb. 21 by Judge Mary L. Cooper in New Jersey District Court, was also a victory for Boehringer Ingelheim Pharmaceuticals Inc., the Ridgefield, Conn.-based company that markets Flomax in the United States.

Ranbaxy filed a notice with the court on Thursday that it was appealing the decision to the...
To view the full article, register now.